Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy

Johanna Buchroithner, Josef Pichler, Christine Marosi, Georg Widhalm, Marcel Seiz-Rosenhagen, Martha Novosielski, Stefan Oberndorfer, Reinhard Ruckser, Karl Rössler, Amedeo Azizi, Gord von Campe, Karin Bordihn, Thomas Felzmann

Research output: Journal article (peer-reviewed)Journal article

17 Citations (Scopus)
Original languageEnglish
Pages (from-to)76-77
Number of pages2
JournalInternational Journal of Clinical Pharmacology and Therapeutics
Issue number1
Publication statusPublished - Jan 2014


  • Brain Neoplasms/therapy
  • Dendritic Cells/immunology
  • Glioblastoma/therapy
  • Humans
  • Immunotherapy
  • Vascular Endothelial Growth Factor A/antagonists & inhibitors

Cite this